DBV Technologies SA banner

DBV Technologies SA
PAR:DBV

Watchlist Manager
DBV Technologies SA Logo
DBV Technologies SA
PAR:DBV
Watchlist
Price: 3.75 EUR -0.13% Market Closed
Market Cap: €1B

DBV Technologies SA
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DBV Technologies SA
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
DBV Technologies SA
PAR:DBV
Other Items
$584k
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Items
€3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Other Items
-€241k
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
25%
Inventiva SA
PAR:IVA
Other Items
-€24.6m
CAGR 3-Years
-59%
CAGR 5-Years
-90%
CAGR 10-Years
N/A
Cellectis SA
PAR:ALCLS
Other Items
-$39.8m
CAGR 3-Years
N/A
CAGR 5-Years
-74%
CAGR 10-Years
-32%
Abivax SA
PAR:ABVX
Other Items
€3.7m
CAGR 3-Years
N/A
CAGR 5-Years
27%
CAGR 10-Years
N/A
No Stocks Found

DBV Technologies SA
Glance View

Market Cap
1B EUR
Industry
Biotechnology

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, Ile-De-France. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.

DBV Intrinsic Value
HIDDEN
Show

See Also

What is DBV Technologies SA's Other Items?
Other Items
584k USD

Based on the financial report for Jun 30, 2025, DBV Technologies SA's Other Items amounts to 584k USD.

What is DBV Technologies SA's Other Items growth rate?
Other Items CAGR 3Y
58%

Over the last year, the Other Items growth was 13%. The average annual Other Items growth rates for DBV Technologies SA have been 58% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett